Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ajay Dhaygude

Showing results (11-20 of 30) with videos related to

Pageof 3
Sort By:
Clinical Kidney Journal|April 4, 2022
Cardiovascular disease and ANCA-associated vasculitis: are we missing a beat?Lauren Floyd, Adam D Morris, Alexander Woywodt, et al.
Clinical Kidney Journal|August 2, 2023
Rituximab in the treatment of primary FSGS: time for its use in routine clinical practice?Adam D Morris, Lauren Floyd, Alexander Woywodt, et al.
Clinical Kidney Journal|May 2, 2022
Remote digital urinalysis with smartphone technology as part of remote management of glomerular disease during the SARS-CoV-2 virus pandemic: single-centre experience in 25 patientsMadelena Stauss, Ajay Dhaygude, Arvind Ponnusamy, et al.
Clinical Kidney Journal|February 13, 2019
Comparing outcomes of biopsy-proven anti-neutrophil cytoplasmic autoantibody-associated glomerulonephritis patients treated with cyclophosphamide in the 20th and 21st centuries: a 23-year studySteven Whatmough, Sophie Fernandez, Niamh Sweeney, et al.
BMC Nephrology|April 22, 2021
Using CPAP in COVID-19 patients outside of the intensive care setting: a comparison of survival and outcomes between dialysis and non-dialysis dependent patientsLauren Floyd, Madelena Stauss, Joshua Storrar, et al.
Nephron. Clinical Practice|August 28, 2004
Prolonged treatment with low-dose intravenous pulse cyclophosphamide may reduce rate of relapse in ANCA-associated vasculitisAjay Dhaygude, Megan Griffith, Thomas Cairns, et al.
BMC Nephrology|May 11, 2021
Correction to: Using CPAP in COVID-19 patients outside of the intensive care setting: a comparison of survival and outcomes between dialysis and non-dialysis dependent patientsLauren Floyd, Madelena Stauss, Joshua Storrar, et al.
Rheumatology International|November 3, 2011
Factors associated with major infections in patients with granulomatosis with polyangiitis and systemic lupus erythematosus treated for deep organ involvementMuir Morton, Sarah Edmonds, Aislinn M Doherty, et al.
Clinical Kidney Journal|April 13, 2018
Frailty and chronic kidney disease: current evidence and continuing uncertaintiesAndrew C Nixon, Theodoros M Bampouras, Neil Pendleton, et al.
Kidney360|September 5, 2023
Low-Dose Intravenous Methylprednisolone in Remission Induction Therapy for ANCA-Associated VasculitisLauren Floyd, Adam D Morris, Anamay Shetty, et al.
Pageof 3

Showing results (11-20 of 30) with videos related to

Sort By:
Pageof 3
Clinical Kidney Journal|April 4, 2022
Cardiovascular disease and ANCA-associated vasculitis: are we missing a beat?Lauren Floyd, Adam D Morris, Alexander Woywodt, et al.
Clinical Kidney Journal|August 2, 2023
Rituximab in the treatment of primary FSGS: time for its use in routine clinical practice?Adam D Morris, Lauren Floyd, Alexander Woywodt, et al.
Clinical Kidney Journal|May 2, 2022
Remote digital urinalysis with smartphone technology as part of remote management of glomerular disease during the SARS-CoV-2 virus pandemic: single-centre experience in 25 patientsMadelena Stauss, Ajay Dhaygude, Arvind Ponnusamy, et al.
Clinical Kidney Journal|February 13, 2019
Comparing outcomes of biopsy-proven anti-neutrophil cytoplasmic autoantibody-associated glomerulonephritis patients treated with cyclophosphamide in the 20th and 21st centuries: a 23-year studySteven Whatmough, Sophie Fernandez, Niamh Sweeney, et al.
BMC Nephrology|April 22, 2021
Using CPAP in COVID-19 patients outside of the intensive care setting: a comparison of survival and outcomes between dialysis and non-dialysis dependent patientsLauren Floyd, Madelena Stauss, Joshua Storrar, et al.
Nephron. Clinical Practice|August 28, 2004
Prolonged treatment with low-dose intravenous pulse cyclophosphamide may reduce rate of relapse in ANCA-associated vasculitisAjay Dhaygude, Megan Griffith, Thomas Cairns, et al.
BMC Nephrology|May 11, 2021
Correction to: Using CPAP in COVID-19 patients outside of the intensive care setting: a comparison of survival and outcomes between dialysis and non-dialysis dependent patientsLauren Floyd, Madelena Stauss, Joshua Storrar, et al.
Rheumatology International|November 3, 2011
Factors associated with major infections in patients with granulomatosis with polyangiitis and systemic lupus erythematosus treated for deep organ involvementMuir Morton, Sarah Edmonds, Aislinn M Doherty, et al.
Clinical Kidney Journal|April 13, 2018
Frailty and chronic kidney disease: current evidence and continuing uncertaintiesAndrew C Nixon, Theodoros M Bampouras, Neil Pendleton, et al.
Kidney360|September 5, 2023
Low-Dose Intravenous Methylprednisolone in Remission Induction Therapy for ANCA-Associated VasculitisLauren Floyd, Adam D Morris, Anamay Shetty, et al.
Pageof 3